Aug 10, 2026
•
12 min read
Plus: four Google legends launch Discovery Loop, autonomous labs get a blueprint, and Jura finds a scaling law for AI in biology.
Aug 3, 2026
10 min read
Plus: GSK backs cell models, AI reopens a cancer trial, and DeepMind breaks up the AlphaFold team.
Jul 30, 2026
7 min read
Plus: AI hunts for cancer before diagnosis, and Atlas wants to predict who will respond before a clinical trial begins.
Jul 29, 2026
19 min read
Derya Unutmaz: “Fable 5 is a great model and they can just restrict it whatever the way they find is right”
Jul 27, 2026
Plus: why biology needs open weights, and AlphaFold3 helps gene editors make fewer mistakes.
Jul 23, 2026
5 min read
Plus: PeptiVerse predicts whether peptides have drug-like properties, and BrainPilot brings AI agents to neuroscience.
Jul 20, 2026
9 min read
Plus: Lila’s scientific-superintelligence claims, Google’s AI biosecurity stack, and a model that reads gene activity as an image.
Jul 16, 2026
Plus: Chai reaches a $3.8B valuation with Lilly, Pfizer and Novartis on board.
Jul 13, 2026
1 min read
Plus: Summer Mode switched on for BAIO.
Jul 9, 2026
Plus: Insilico’s AI-designed drug enters Phase III, Biohub finds psoriasis targets in skin cells, and ATHENA teaches medical AI to check its evidence.
